Brief: Centogene And The Michael J. Fox Foundation Announce Research Project To Validate Genetic Risk Factors Of Parkinson’s Disease Using Multiomics
Jan 23 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE AND THE MICHAEL J. FOX FOUNDATION ANNOUNCE
RESEARCH
PROJECT TO VALIDATE GENETIC RISK FACTORS OF PARKINSON’S DISEASE
USING MULTIOMICS
Source text for Eikon: ID:nGNXcfWlpW
Further company coverage: 39K.MU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice